| 1 Public Awareness |
| •Public health programs across the countries |
| 2 Prevent the spread of infection |
| •Expansion of the access to clean water and appropriate sanitation |
| •Reduction of infection in hospitals and care settings |
| 3 Reduction of antibiotic use in agriculture |
| •Restriction on the use of highly critical antibiotics in farming |
| •Prevention of antibiotic dissemination into environment |
| 4 Global surveillance |
| •Major surveillance programs including USA Global Health Security Agenda, UK Fleming Fund, WHO Global AMR Surveillance System |
| •Easy data accessibility around the world |
| 5 Rapid new diagnostics |
| •Support research and innovation in this area |
| 6 Use of alternative antimicrobials |
| •Vaccines |
| •Bacteriophage therapy, engineered bacteria, antimicrobial peptides |
| 7 Recognition of researchers in infectious disease |
| •Clear career paths and rewards for scientists in the field |
| 8 Global Innovation Fund |
| •Link and expand major initiatives |
| •Fund different projects (e.g. R&D that might lack commercial imperative) |
| 9 Better investment for new drugs |
| •Governments should find new ways to reward innovation |
| •Link between profit and volume of sales should be reduced |
| 10 Global Coalition for real action |
| •Joint efforts from G20 and UN are needed |
| •Step change plan to fight AMR has to be redesigned |
